Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections: A Target Trial Emulation

NCT06126263 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.

NCT NCT06126263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06126263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections: A Target Trial Emulation
Lead sponsor
National Institutes of Health Clinical Center (CC)
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2023
Completion date
June 30, 2024
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection, bacterial, infection, bloodstream, invasive group a beta-haemolytic streptococcal disease, necrotizing soft tissue infection, streptococcal sepsis, streptococcal toxic shock syndrome